Round 1 of Australia’s CRISPR patent dispute concludes Sep 19 2018 Browse archives for September 19, 2018 Posted in Life Sciences, Patents Tagged with Asia Pacific, Australia, Cas9, CRISPR, genome editing, guide RNA, Office Decisions, Patents, priority Share FacebookTwitterLinkedInPinterest The first round of the Australian CRISPR patent dispute has concluded, with the patent office ruling that claims directed to platform CRISPR technologies lack novelty and an inventive step. Read More
